• Skip to main content
Vestex Protects
  • For Brand
    Manufacturers
    • Why Become A Licensee
    • Product Development Process
    • How To Become A Licensee
    • Target Markets
  • For Fabric
    Finishing Mills
    • Why Become A Certified Application Partner
    • How To Become A Certified Application Partner
    • Target Markets
  • Buy
    Products
  • Effectiveness
    + Safety
    • FDA Regulatory Clearance
    • Effectiveness
    • Endorsements + Awards
    • VESTEX® +
      COVID-19
  • About
    • Leadership
    • Company History
    • News
  • Contact
Vestex Protects

Effectiveness + Safety

  • FDA Regulatory Clearance
  • Effectiveness
  • Endorsements + Awards
  • VESTEX® + COVID-19

For Brand Manufacturers

  • Why Become A Licensee
  • Product Development Process
  • How To Become A Licensee
  • Target Markets

For Fabric Finishing Mills

  • Why Become A Certified Application Partner
  • How To Become A Certified Application Partner
  • Target Markets

About Us

  • Leadership
  • Company History
  • News
  • Contact Us

How to Buy

  • Buy Licensee Products

VESTEX® + COVID-19

The FDA has established a hierarchy of susceptibility1 in descending order of resistance by which the FDA recognizes that bacterial spores and vegetative bacteria (such as MRSA) are more resistant to kill than lipid viruses (such as Coronaviruses).

Based on the hierarchy of susceptibility, VESTEX®’s ability to reduce retention of MRSA on the surface of the apparel would also apply to COVID-19.

COVID-19 is spread mainly via aerosolized droplets from an infected person’s cough or sneeze. VESTEX® repels fluids and significantly reduces the number of microorganisms that remain on the fabric.

hierarchy of susceptibility pyramid

While the FDA has not yet reviewed the ability of products protected by VESTEX® to reduce COVID-19, preliminary research has documented results equal to or better than the reduction of MRSA. This research is being assessed analytically and VESTEX® does intend to seek FDA clearance for specific claims relating to retention of Coronaviruses on VESTEX®-protected fabrics.

Watch Video: Effectiveness of VESTEX® Microbial Protection

1 CDC Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. William A. Rutala, Ph.D., M.P.H.1,2, David J. Weber, M.D., M.P.H.1,2, and the Healthcare Infection Control Practices Advisory Committee (HICPAC)

Next under VESTEX® Technology

  • FDA Regulatory Clearance
  • Effectiveness
  • Endorsements + Awards
  • VESTEX® + COVID-19
Vestex Protects logo

Call 407-488-0920 or email us.

  • For Brand Manufacturers
  • For Fabric Finishing Mills
  • Buy Products
  • Effectiveness + Safety
  • Contact Us
  • The ability of VESTEX® to reduce the retention of MRSA on the fabric surface has not been shown to correlate with the reduction of infections.
  • Clinical studies to evaluate reduction of infection have not been performed for this device.
  • VESTEX® Apparel is not intended to replace personal protective equipment.
  • VESTEX® does not replace PPE worn for specific use and during episodes of expected blood, body fluid and other potentially infectious material (OPIM) exposure.

Privacy Notice | Terms of Use

Copyright © 2023 VESTEX®